Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Markenson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Laboratory and Clinical Medicine|January 1, 1980
Supressor monocytes in patients with systemic lupus erythematosus. Evidence of suppressor activity associated with a cell-free soluble product of monocytesJ A Markenson, M D Lockshin, L Fuzesi, et al.
Annals of the Rheumatic Diseases|February 1, 1983
Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosisM D Lockshin, J A Markenson, L Fuzesi, et al.
Osteoarthritis and Cartilage|May 13, 2009
Efficacy of combined local mechanical vibrations, continuous passive motion and thermotherapy in the management of osteoarthritis of the kneeG S Kitay, M J Koren, D L Helfet, et al.
Archives of Internal Medicine|October 1, 1982
Systemic lupus erythematosus in men. Genetic and endocrine featuresR D Inman, L Jovanovic, J A Markenson, et al.
Clinical and Experimental Immunology|February 1, 1975
The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexesJ A Markenson, C A Daniels, A L Notkins, et al.
The American Journal of the Medical Sciences|July 1, 1974
The lack of association between rheumatoid factor and hepatitis B antigenJ H Hoofnagle, J A Markenson, C A Daniels, et al.
Pharmacotherapy|November 11, 1999
Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxibS Z Zhao, J I McMillen, J A Markenson, et al.
Transfusion|February 1, 1991
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patientsH M Lazarus, S B Cohen, D O Clegg, et al.
Arthritis and Rheumatism|July 24, 2001
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or kneeT Pincus, G G Koch, T Sokka, et al.
Arthritis and Rheumatism|November 12, 1998
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptidesL W Moreland, E E Morgan, T C Adamson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Laboratory and Clinical Medicine|January 1, 1980
Supressor monocytes in patients with systemic lupus erythematosus. Evidence of suppressor activity associated with a cell-free soluble product of monocytesJ A Markenson, M D Lockshin, L Fuzesi, et al.
Annals of the Rheumatic Diseases|February 1, 1983
Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosisM D Lockshin, J A Markenson, L Fuzesi, et al.
Osteoarthritis and Cartilage|May 13, 2009
Efficacy of combined local mechanical vibrations, continuous passive motion and thermotherapy in the management of osteoarthritis of the kneeG S Kitay, M J Koren, D L Helfet, et al.
Archives of Internal Medicine|October 1, 1982
Systemic lupus erythematosus in men. Genetic and endocrine featuresR D Inman, L Jovanovic, J A Markenson, et al.
Clinical and Experimental Immunology|February 1, 1975
The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexesJ A Markenson, C A Daniels, A L Notkins, et al.
The American Journal of the Medical Sciences|July 1, 1974
The lack of association between rheumatoid factor and hepatitis B antigenJ H Hoofnagle, J A Markenson, C A Daniels, et al.
Pharmacotherapy|November 11, 1999
Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxibS Z Zhao, J I McMillen, J A Markenson, et al.
Transfusion|February 1, 1991
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patientsH M Lazarus, S B Cohen, D O Clegg, et al.
Arthritis and Rheumatism|July 24, 2001
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or kneeT Pincus, G G Koch, T Sokka, et al.
Arthritis and Rheumatism|November 12, 1998
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptidesL W Moreland, E E Morgan, T C Adamson, et al.
Pageof 2